Caitlin Clark may be an all-star on the basketball court, but she couldn’t beat Eli Manning when it came to a game of Pop-A-Shot. On the latest episode of The Eli Manning Show, the former NFL ...

Eli Lilly is set to keep growing its revenue at a strong pace in the next five years. The company is likely to add important medicines to its lineup. Eli Lilly's shares look attractive right now ...

Eli Manning’s still got it — even off the football field. The legendary Giants quarterback, 44, faced off against WNBA star Caitlin Clark in a recent round of Pop-A-Shot on “The Eli Manning ...

For years, Eli Lilly has been generating solid growth numbers -- but lately, they've been accelerating rapidly. The company is coming off a solid quarter where its revenue rose by 45% for the last ...

Eli Lilly has launched new 7.5 mg and 10 mg single-dose vials of Zepbound (tirzepatide), priced at $499 per month under the newly introduced Zepbound Self Pay Journey Program. The company said ...

Eli Lilly said Tuesday that it will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells, as the pharma giant seeks to draw patients away from ...

Eli Manning may not be done as a Giant just yet. The two-time Super Bowl MVP, who missed out on his first try for the Pro Football Hall of Fame earlier this month, said Friday he would have ...

US President Donald Trump watched translated excerpts of an interview given by captivity survivor Eli Sharabi to the "Uvda" program, and invited him and other captivity survivors to the White ...

Rep. Eli Crane, R-Ariz., said this week he was drafting articles of impeachment against U.S. District Judge Paul Engelmayer of the U.S Southern District of New York, who on Saturday blocked the ...

Former Giants quarterback Eli Manning has previously expressed interest in NFL ownership, specifically with his former team. “It’s definitely something of interest,” Manning said in an ...

At least $241 million in taxpayer funds was spent on transgender surgeries and animal experiments, prompting a congressional lawmaker to question the rationale behind the expenditures. Rep.

Late-breaking results from Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) found adolescent patients (ages 12 to under 18) with severe alopecia areata (AA) treated with once-daily ...